Alvimopan Dihydrate is a peripherally acting mu-opioid receptor antagonist used clinically to accelerate gastrointestinal recovery following bowel resection surgery. By selectively blocking mu-opioid receptors… Read more
Alvimopan Dihydrate is a peripherally acting mu-opioid receptor antagonist used clinically to accelerate gastrointestinal recovery following bowel resection surgery. By selectively blocking mu-opioid receptors in the gut without crossing the blood-brain barrier, this medication mitigates opioid-induced bowel dysfunction and facilitates a faster return to normal intestinal motility. This category features high-quality reference standards of Alvimopan Dihydrate, as well as its related impurities, metabolites, and stable isotope-labelled compounds. These materials are critical for laboratories engaged in rigorous analytical testing, impurity profiling, and method validation to ensure the quality and safety of drug products. Pharmaceutical researchers rely on these standards to accurately identify and quantify degradants and by-products throughout the drug development lifecycle, supporting compliance with stringent regulatory requirements for active pharmaceutical ingredients.